| Zaman aralığı | Tahmini Fiyat | Geçmiş | Tarihsel | İç yüzü |
|---|---|---|---|---|
| Yarın | $72.09 ▲ +1.15% | Dün | $70.93 ▼ -0.48% | Tomorrow's Spyre Therapeutics Inc. Common Stock (SYRE) setup is anchored to $71.27 and targets $72.09 (+1.15%). The near-term read is upside; watch $73.41 / $69.13 because daily realized volatility is about 5.93%. |
Tomorrow's Spyre Therapeutics Inc. Common Stock (SYRE) setup is anchored to $71.27 and targets $72.09 (+1.15%). The near-term read is upside; watch $73.41 / $69.13 because daily realized volatility is about 5.93%. | ||||
| Hafta | $73.82 ▲ +3.58% | Geçen hafta | $70.20 ▼ -1.50% | The 7-day Spyre Therapeutics Inc. Common Stock model moves from $70.20 to $73.82 (+3.58%). It gives upside momentum context for this stock, so breaks around $73.41 / $69.13 matter more than a single tick. |
The 7-day Spyre Therapeutics Inc. Common Stock model moves from $70.20 to $73.82 (+3.58%). It gives upside momentum context for this stock, so breaks around $73.41 / $69.13 matter more than a single tick. | ||||
| Ay | $76.70 ▲ +7.61% | Geçen ay | $68.99 ▼ -3.20% | The 1-month Spyre Therapeutics Inc. Common Stock target is $76.70 (+7.61%), compared with the live reference near $71.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Spyre Therapeutics Inc. Common Stock target is $76.70 (+7.61%), compared with the live reference near $71.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Yıl | $81.01 ▲ +13.67% | Geçen sene | $67.18 ▼ -5.74% | The 1-year Spyre Therapeutics Inc. Common Stock scenario points to $81.01 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Spyre Therapeutics Inc. Common Stock scenario points to $81.01 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Yıl | $91.12 ▲ +27.86% | 5 Yıl Önce | $62.93 ▼ -11.70% | The 5-year Spyre Therapeutics Inc. Common Stock view is $91.12 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Spyre Therapeutics Inc. Common Stock view is $91.12 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Gösterge | Değer | Sinyal |
|---|---|---|
| Price | $71.27 | Mid |
| Daily Change | -2.89% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $71.27 | Daily Change | -2.89% |
| Market Cap | $6.61B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.